MRCA Pharmaceutical Benefits Scheme (No. MRCC 44/2013)
8Application of the Scheme
Start here
Get a plain-English read of 8
Turn the raw legal text into a practical explanation grounded in MRCA Pharmaceutical Benefits Scheme (No. MRCC 44/2013).
8 Application of the Scheme
A provision of the Scheme applies subject to this Special Arrangement.
(9) The special arrangement referred to in paragraph (1)(a) has effect as if subsection 9(1) was omitted and replaced with the following:
(1) Division 2 of Part 2 of this Special Arrangement applies to the supply of a pharmaceutical benefit by an approved supplier based on a paper-based prescription (excluding a medication chart prescription) written as the result of a telehealth attendance or phone attendance provided on or after 20 March 2020 to which an item in a Fee Schedule (a document incorporated as in force from time to time for the purposes of the Treatment Principles) applies.
(10) The special arrangement referred to in paragraph (1)(a) has effect as if subsection 9(4) of the instrument is omitted.
(11) The special arrangement referred to in paragraph (1)(a) has effect as if subsection 10(4) of the instrument is replaced with the following:
(4) If the prescription is or would be an authority prescription, the supplier may supply the Pharmaceutical benefit under this section only if prior approval has been obtained.
16AA Supply of pharmaceutical benefit on basis of medication chart prescription
(1) A Pharmaceutical benefit may only be supplied on the basis of a medication chart prescription by:
(a) if the person in respect of whom the Pharmaceutical benefit is to be supplied is receiving treatment in or at a residential care service – a Community Pharmacist; or
(b) if the person in respect of whom the Pharmaceutical benefit is to be supplied is receiving treatment in or at an approved hospital—a Community Pharmacist or the Approved Hospital Authority.
(2) A Community Pharmacist may supply a Pharmaceutical benefit on the basis of a medication chart prescription only if:
(a) the Community Pharmacist has seen:
(i) the medication chart by which the prescription was written; or
(ii) a copy of so much of the chart as would indicate that subsections 11B(3) and (4) (if applicable) have been complied with; and
(b) the date on which the Pharmaceutical benefit is supplied is:
(i) the Community Pharmacist’s name and any approval number under section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017;
(ii) an identification number for the supply;
(iii) the date on which the Pharmaceutical benefit is supplied.
(3) For paragraph (2)(b), the period of validity of a medication chart for a person receiving treatment in or at a residential care service:
(a) starts on the day in a calendar month (the first calendar month) when the first prescription for a Pharmaceutical benefit is written in the medication chart; and